Director/PDMR Shareholding

Forterra plc

31 May 2024

 

31^st May 2024

Forterra plc

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 17 September 2023 of share options granted to management under the 2020 Performance Share Plan (PSP), the Company was notified on the 28 May 2024 that on the 28 May 2024 the following exercise and sale transactions took place:

Darren Rix exercised options granted under the PSP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities.

Name	Status	No. of share options exercised	Sale Date	Number of shares sold	Price	Number of shares retained	Beneficial interest	% of ISC
Darren Rix	PDMR	27,982	28/05/24	13,198	£1.642	14,784	22,914	< 1%

The 2020 PSP awards were granted with all of the awards subject to an TSR performance condition. The TSR performance condition vested at 53.9%. The Remuneration Committee determined that, in accordance with the rules of the scheme, participants would receive dividend equivalent shares at the rate of 0.1437 additional share for every vesting share.  The Remuneration Committee also agreed to waive the 1p per option cost upon exercise.   

The shares to be retained by management are to be transferred to management by the Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:	[phone]
Frances Tock (Company Secretary)
FTI Consulting:	[phone]
Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Darren Rix
2.	Reason for the notification
a)	Position/status	PDMR (Director)
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Forterra plc
b)	LEI	213800O5DD6ATBVJAD23
4.	Details of the transaction(s):
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1p each GB00BYYW3C20
b)	Nature of the transaction	Acquisition of shares for no consideration pursuant to the exercise of nominal cost options (with the 1p option cost waived by the Company) granted under the PSP scheme on 17 September 2020 and vesting on 17 September 2023
c)	Price(s) and volume(s)	Transaction Price(s) Volume(s) £Nil £1.642 £Nil 27,982 options vesting 13,198 shares sold to settle tax and NI 14,784 shares acquired
d)	Aggregated information	Transaction Price(s) Volume(s) Total  Sale £1.642 13,198 £21,671

 

END